Journals / Turkish Journal of Obstetrics and Gynecology / 2020 / Cilt: 17 - Sayı: 4

Comparison of intramuscular versus subcutaneous aqueous progesterone for luteal phase support in artificially prepared frozen embryo transfer cycles

Hormon replasmanı ile hazırlanmış dondurulmuş embriyo transfer sikluslarında intramusküler progesteron ve su bazlı subkütanöz progesteronun luteal faz desteği açısından karşılaştırılması

Pages
16–22
Publication Date
2022-11-02
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The inclusion criteria were as follows: females aged

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Cryopreservation of embryos for future transfer attempts has noticeably increased in the last decade, especially due to the technological developments in in vitro fertlization (IVF) laboratories.
📊
Key Findings & Data:Materials and Methods: This retrospective, single-centre cohort study included a total of 507 AC-FET cycles performed between June 2018 and April 2020.
💡
Conclusion & Impact:The inclusion criteria were as follows: females aged
🔬Design:Research Article
📍Scope:2018 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: Cryopreservation of embryos for future transfer attempts has noticeably increased in the last decade, especially due to the technological developments in in vitro fertlization (IVF) laboratories. In parallel, different progesterone (P) replacement regimens preceding artificially prepared frozen embryo transfer (AC-FET) attempts, especially with respect to the route of application and dosing scheme, have been widely argued so far. We aimed to provide more information about the efficacy profile of novel subcutaneous aqueous progesterone (SP) in AC-FET cycles. Materials and Methods: This retrospective, single-centre cohort study included a total of 507 AC-FET cycles performed between June 2018 and April 2020. Three hundred forty-nine (68.8%) patients received 50 mg of intramuscular progesterone as once daily, 158 (31.2%) patients received 25 mg of SP as twice daily. Only, the first and single blastocyst transfers from the same cohort were accepted. The inclusion criteria were as follows: females aged

Özet

Amaç: Son on yılda, özellikle in vitro fertilizasyon (IVF) laboratuvarında meydana gelen teknolojik gelişmeleri takiben, embriyo kriyoprezervasyonu ve bu embriyoların gelecekteki transfer işlem sayıları fark edilir bir şekilde artmıştır. Buna paralel olarak, hormon replasmanı ile hazırlanmış dondurulmuşçözülmüş embriyo transferi (HR-DÇET) öncesi uygulanan progesteron (P) yerine koyma tedavileri de, özellikle uygulama yolu ve dozları açısından daha çok tartışılmaya başlanmıştır. Bu çalışmada, yeni bir formülasyon olan su bazlı subkütanöz progesteronun (SP) HR-DÇET tedavilerindeki etkinliği hakkında daha fazla bilgi edinmeyi amaçladık. Gereç ve Yöntemler: Retrospektif, tek merkezli kohort çalışması olarak dizayn edilen bu çalışma, Haziran 2018 ve Nisan 2020 tarihleri arasında yapılan 507 tane HR-DÇET siklusunu içermektedir. Hastaların 349’unda (%68,8) 50 mg intramusküler progesteron günde bir defa, 158’inde (%32,2) ise 25 mg SP günde iki defa kullanıldı. Aynı tedavi siklusunda elde edilen ve dondurulan blastokistlerden sadece bir tanesinin transferi değerlendirmeye alındı. Aynı hastanın tekrarlayan tedavi siklusları çalışmaya dahil edilmedi. Dahil edilme kriterleri; kadın yaşı

🔖

Cite This Article

TURGUT, E. N., BOYNUKALIN, F. K., GÜLTOMRUK, M., YARKINER, Z., BAHÇECİ, M. (2022). Comparison of intramuscular versus subcutaneous aqueous progesterone for luteal phase support in artificially prepared frozen embryo transfer cycles. Turkish Journal of Obstetrics and Gynecology, Cilt: 17 - Sayı: 4, 16–22. https://ajindex.com/articles/612948

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Trounson A, Mohr L. Human pregnancy following cryopreservation, thawing and transfer of an eight-cell embryo. Nature 1983;305:707- 9
  2. Centers for Disease Control and Prevention. ASFRM, Society for Assisted Reproductive Technology 2016 Assisted Reproductive Technology National Summary Report. US Department of Health and Human Services. 2018. https://www.cdc.gov/art/pdf/2016- report/ART-2016-National-Summary-Report.pdf 3. Ghobara T, Gelbaya TA, Ayeleke RO. Cycle regimens for frozen-thawed embryo transfer. Cochrane Database Syst Rev 2017;7:CD003414
  3. Ortega I, Velasco JAG. Progesterone supplementation in the frozen embryo transfer cycle. Curr Opin Obstet Gynecol 2015;27:253-7
  4. Shapiro D, Boostanfar R, Silverberg K, Yanushpolsky EH. Examining the evidence: progesterone supplementation during fresh and frozen embryo transfer. Reprod Biomed Online 2014;29(Suppl 1):S1-14; quiz S15‐6
  5. Vaisbuch E, Leong M, Shoham Z. Progesterone support in IVF: is evidence-based medicine translated to clinical practice? A worldwide webbased survey. Reprod Biomed Online 2012;25:139-45
  6. Klement AH, Samara N, Weintraub A, Mitri F, Bentov Y, Chang P, et al. Intramuscular Versus Vaginal Progesterone Administration in Medicated Frozen Embryo Transfer Cycles: A Randomized Clinical Trial Assessing Sub-Endometrial Contractions. Gynecol Obstet Invest 2018;83:40-4
  7. Shapiro DB, Pappadakis JA, Ellsworth NM, Hait HI, Nagy ZP. Progesterone replacement with vaginal gel versus i.m. injection: cycle and pregnancy outcomes in ivf patients receiving vitrified blastocysts. Hum Reprod 2014;29:1706-11
  8. Shiba R, Kinutani M, Okano S, Kawano R, Kikkawa Y. Efficacy of Four Vaginal Progesterones for Luteal Phase Support in FrozenThawed Embryo Transfer Cycles: A Randomized Clinical Trial. Reprod Med Biol 2019;19:42-9
  9. Groenewoud ER, Cantineau AEP, Kollen BJ, Macklon NS, Cohlen BJ. What is the optimal means of preparing the endometrium in frozen-thawed embryo transfer cycles? A systematic review and meta-analysis. Hum Reprod Update 2017;23:255-61
  10. Casper RF. Luteal phase support for frozen embryo transfer cycles: intramuscular or vaginal progesterone? Fertil Steril 2014;101:627- 8
  11. Cometti B. Pharmaceutical and clinical development of a novel progesterone formulation. Acta Obstet Gynecol Scand 2015;94(Suppl 161):28-37
  12. Baker VL, Jones CA, Doody K, Foulk R, Yee B, Adamson GD, et al. A randomized, controlled trial comparing the efficacy and safety of aqueous subcutaneous pro